Cencora ROE 2010-2025 | COR
Current and historical return on equity (ROE) values for Cencora (COR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Cencora ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $1.69B | $1.18B | 199.76% |
| 2024-12-31 | $1.40B | $0.36B | 162.47% |
| 2024-09-30 | $1.51B | $0.79B | 145.94% |
| 2024-06-30 | $1.86B | $1.06B | 185.01% |
| 2024-03-31 | $1.85B | $1.23B | 191.33% |
| 2023-12-31 | $1.87B | $1.06B | 236.46% |
| 2023-09-30 | $1.75B | $0.67B | 321.40% |
| 2023-06-30 | $1.69B | $0.92B | 428.39% |
| 2023-03-31 | $1.62B | $0.51B | 550.94% |
| 2022-12-31 | $1.73B | $0.07B | 441.05% |
| 2022-09-30 | $1.70B | $0.07B | 324.24% |
| 2022-06-30 | $1.84B | $0.52B | 282.41% |
| 2022-03-31 | $1.73B | $0.91B | 276.43% |
| 2021-12-31 | $1.61B | $0.60B | 433.29% |
| 2021-09-30 | $1.54B | $0.58B | 1633.95% |
| 2021-06-30 | $-3.74B | $0.41B | 1430.37% |
| 2021-03-31 | $-3.75B | $-0.10B | -596.42% |
| 2020-12-31 | $-3.22B | $-0.51B | -203.89% |
| 2020-09-30 | $-3.41B | $-0.84B | -137.71% |
| 2020-06-30 | $1.57B | $3.97B | 45.72% |
| 2020-03-31 | $1.58B | $3.71B | 49.18% |
| 2019-12-31 | $0.65B | $3.07B | 21.30% |
| 2019-09-30 | $0.86B | $2.99B | 27.83% |
| 2019-06-30 | $0.96B | $3.11B | 30.94% |
| 2019-03-31 | $0.93B | $3.04B | 29.69% |
| 2018-12-31 | $1.19B | $3.17B | 37.03% |
| 2018-09-30 | $1.66B | $3.05B | 52.78% |
| 2018-06-30 | $1.08B | $3.28B | 37.31% |
| 2018-03-31 | $0.85B | $3.36B | 31.46% |
| 2017-12-31 | $0.98B | $2.88B | 39.03% |
| 2017-09-30 | $0.36B | $2.06B | 15.67% |
| 2017-06-30 | $0.85B | $2.55B | 36.62% |
| 2017-03-31 | $1.15B | $2.53B | 53.29% |
| 2016-12-31 | $1.35B | $2.12B | 64.69% |
| 2016-09-30 | $1.43B | $2.13B | 76.17% |
| 2016-06-30 | $1.64B | $1.88B | 109.79% |
| 2016-03-31 | $1.51B | $2.19B | 106.14% |
| 2015-12-31 | $0.39B | $1.30B | 28.99% |
| 2015-09-30 | $-0.14B | $0.62B | -9.39% |
| 2015-06-30 | $-0.43B | $1.58B | -24.00% |
| 2015-03-31 | $-0.66B | $1.92B | -34.61% |
| 2014-12-31 | $0.03B | $1.77B | 1.68% |
| 2014-09-30 | $0.27B | $1.96B | 13.15% |
| 2014-06-30 | $0.26B | $1.99B | 11.91% |
| 2014-03-31 | $0.44B | $2.15B | 19.27% |
| 2013-12-31 | $0.31B | $2.25B | 13.12% |
| 2013-09-30 | $0.43B | $2.32B | 18.43% |
| 2013-06-30 | $0.55B | $2.42B | 22.85% |
| 2013-03-31 | $0.56B | $2.35B | 22.21% |
| 2012-12-31 | $0.73B | $2.34B | 27.18% |
| 2012-09-30 | $0.72B | $2.46B | 25.56% |
| 2012-06-30 | $0.70B | $2.93B | 24.11% |
| 2012-03-31 | $0.71B | $2.95B | 23.66% |
| 2011-12-31 | $0.71B | $2.91B | 23.36% |
| 2011-09-30 | $0.71B | $2.87B | 23.21% |
| 2011-06-30 | $0.70B | $3.20B | 22.85% |
| 2011-03-31 | $0.68B | $3.13B | 22.67% |
| 2010-12-31 | $0.65B | $2.96B | 22.13% |
| 2010-09-30 | $0.64B | $2.95B | 22.20% |
| 2010-06-30 | $0.63B | $2.93B | 22.28% |
| 2010-03-31 | $0.58B | $2.83B | 20.99% |
| 2009-12-31 | $0.54B | $2.74B | 19.75% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.164B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.115B | 27.47 |
| CVS Health (CVS) | United States | $75.901B | 9.43 |
| Elevance Health (ELV) | United States | $65.016B | 8.74 |
| DiDi Global (DIDIY) | China | $25.650B | 27.25 |
| Labcorp Holdings (LH) | United States | $21.906B | 17.29 |
| Natera (NTRA) | United States | $18.548B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.156B | 0.00 |
| ICON (ICLR) | Ireland | $14.957B | 14.39 |
| CochLear (CHEOY) | Australia | $13.609B | 0.00 |
| Solventum (SOLV) | United States | $12.725B | 13.47 |
| Medpace Holdings (MEDP) | United States | $12.583B | 33.30 |
| Revvity (RVTY) | United States | $11.135B | 19.32 |
| Viatris (VTRS) | United States | $10.786B | 3.71 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.074B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.765B | 17.17 |
| HealthEquity (HQY) | United States | $8.282B | 36.28 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.001B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.183B | 30.52 |
| Amplifon S.p.A (AMFPF) | Italy | $5.058B | 27.69 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.446B | 19.58 |
| Surgery Partners (SGRY) | United States | $2.862B | 37.22 |
| Organon (OGN) | United States | $2.636B | 2.80 |
| GeneDx Holdings (WGS) | United States | $2.619B | 60.38 |
| Concentras Parent (CON) | United States | $2.589B | 14.96 |
| Alignment Healthcare (ALHC) | United States | $2.331B | 0.00 |
| Progyny (PGNY) | United States | $1.957B | 43.08 |
| PACS (PACS) | United States | $1.757B | 0.00 |
| Premier (PINC) | United States | $1.749B | 13.27 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Ardent Health (ARDT) | United States | $1.532B | 6.53 |
| Teladoc Health (TDOC) | United States | $1.321B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.192B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.799B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.740B | 6.93 |
| CareDx (CDNA) | United States | $0.708B | 11.06 |
| Embecta (EMBC) | United States | $0.628B | 4.23 |
| So-Young (SY) | China | $0.507B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.489B | 0.00 |
| Nutex Health (NUTX) | United States | $0.474B | 7.18 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| Omada Health (OMDA) | $0.468B | 0.00 | |
| LifeMD (LFMD) | United States | $0.464B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.456B | 10.27 |
| SBC Medicals (SBC) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.401B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.323B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.276B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |